Lynch Asset Management, Inc. Novo Nordisk A S Transaction History
Lynch Asset Management, Inc.
- $247 Million
- Q4 2024
A detailed history of Lynch Asset Management, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Lynch Asset Management, Inc. holds 106,950 shares of NVO stock, worth $9.41 Million. This represents 3.73% of its overall portfolio holdings.
Number of Shares
106,950
Previous 106,300
0.61%
Holding current value
$9.41 Million
Previous $12.7 Million
27.32%
% of portfolio
3.73%
Previous 5.33%
Shares
5 transactions
Others Institutions Holding NVO
# of Institutions
1,904Shares Held
317MCall Options Held
5.49MPut Options Held
7.77M-
Jennison Associates LLC19.9MShares$1.75 Billion1.06% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.26 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.26 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.17 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$1.07 Billion3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $199B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...